Approaches to ascertaining comorbidity information: validation of routine hospital episode data with clinician-based case note review

Soo, Martin; Robertson, Lynn M.; Ali, Tariq; Clark, Laura E.; Fluck, Nicholas; Johnston, Marjorie; Marks, Angharad; Prescott, Gordon J.; Smit, William Cairns S.; Black, Corri
May 2014
BMC Research Notes;2014, Vol. 7 Issue 1, p2
Academic Journal
Background In clinical practice, research, and increasingly health surveillance, planning and costing, there is a need for high quality information to determine comorbidity information about patients. Electronic, routinely collected healthcare data is capturing increasing amounts of clinical information as part of routine care. The aim of this study was to assess the validity of routine hospital administrative data to determine comorbidity, as compared with clinician-based case note review, in a large cohort of patients with chronic kidney disease. Methods A validation study using record linkage. Routine hospital administrative data were compared with clinician-based case note review comorbidity data in a cohort of 3219 patients with chronic kidney disease. To assess agreement, we calculated prevalence, kappa statistic, sensitivity, specificity, positive predictive value and negative predictive value. Subgroup analyses were also performed. Results Median age at index date was 76.3 years, 44.0% were male, 67% had stage 3 chronic kidney disease and 31% had at least three comorbidities. For most comorbidities, we found a higher prevalence recorded from case notes compared with administrative data. The best agreement was found for cerebrovascular disease (κ = 0.80) ischaemic heart disease (κ = 0.63) and diabetes (κ = 0.65). Hypertension, peripheral vascular disease and dementia showed only fair agreement (κ = 0.28, 0.39, 0.38 respectively) and smoking status was found to be poorly recorded in administrative data. The patterns of prevalence across subgroups were as expected and for most comorbidities, agreement between case note and administrative data was similar. Agreement was less, however, in older ages and for those with three or more comorbidities for some conditions. Conclusions This study demonstrates that hospital administrative comorbidity data compared moderately well with case note review data for cerebrovascular disease, ischaemic heart disease and diabetes, however there was significant under-recording of some other comorbid conditions, and particularly common risk factors.


Related Articles

  • The relationship between diabetes and atherosclerosis. Beckwith, Sue // British Journal of Cardiac Nursing;May2014, Vol. 9 Issue 5, p237 

    Diabetes is characterised by accelerated atherosclerosis with widely distributed vascular lesions. Both the risk and rate of development of these lesions are directly influenced by the glycaemic fluctuations and lipid imbalances characteristic of diabetes. This article looks at the mechanisms...

  • SYNTAX score II predicted mortality after PCI or CABG in complex CAD better than SYNTAX score.  // Annals of Internal Medicine;7/16/2013, Vol. 159 Issue 2, pJC5 

    The article focuses on the importance of the SYNTAX Score II, which determines the alternative treatment for patients with complex coronary disease (CAD). It informs that the score II includes clinical variables including peripheral vascular disease, creatinine clearance and chronic obstructive...

  • Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study. Modi, Rohit Ramesh; Behera, Umesh Chandra; Sureka, Shraddha Pawan // British Journal of Ophthalmology;Jun2014, Vol. 98 Issue 6, p846 

    A letter to the editor is presented in response to the article "Increased Risk of Coronary Heart Disease in Male Patients With Central Serous Chorioretinopathy: Results of a Population-Based Cohort Study" by S. Chen, Y. Chen and L. Lian, which appeared in a previous issue of the journal.

  • The Relation of Left Ventricular Diastolic Dysfunction and Increased Left Ventricular Mass with Blood Pressure Variability in Non-Established Hypertensive Patients. Mohsen Ali Mahmoud Salama; Yasser El Sayed Mohammed Hasan; Moataz Abd Al Rahman Abd Al Salam Farag // Egyptian Journal of Hospital Medicine;4/11/2019, Vol. 75 Issue 6, p3013 

    Background: long term high blood pressure is a major risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss and chronic kidney disease. Objective: the aim of this study is to demonstrate the relation between left ventricular diastolic...

  • Mortality from cardiovascular disease among interregional migrants in England and Wales. Strachan, D.P.; Leon, D.A. // BMJ: British Medical Journal (International Edition);2/18/95, Vol. 310 Issue 6977, p423 

    Investigates the extent to which geographical variations in mortality from ischemic heart disease and stroke in Great Britain are influenced by factors in early life or in adulthood. Genetic factors; Environmental exposures; Lifestyle.

  • Role of Lp(a) in coronary disease and stroke is controversial. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;03/25/98, Vol. 11 Issue 3, p28 

    Presents studies suggesting that lipoprotein (a) (Lp[a]) is a risk factor for coronary artery disease (CAD) and stroke. Differences in measurement methods; Possibility that Lp(a) may increase risk only in people with hypercholesterolemia; Reduction of elevated low-density lipoprotein...

  • Healthy coffee.  // New Scientist;10/20/90, Vol. 128 Issue 1739, p19 

    Reports on a study published in the October 11, 1990 issue of the 'New England Journal of Medicine,' which shows that four or more cups of coffee a day do not predispose a person to heart disease or strokes. Two-year study on male coffee drinkers; Contradiction of earlier investigations blaming...

  • Lipoprotein (a) and Stroke: An Overview. Christogiannis, Leonidas; Milionis, Haralampos J.; Elisaf, Moses // Open Clinical Chemistry Journal;2010 Special Issue, p38 

    Stroke remains a major cause of mortality and long term severe disability worldwide. Lipoprotein (a) [Lp(a)] is a predictor of many forms of vascular disease, and may serve as a tool in identifying subjects at risk. Despite accumulating evidence from cross sectional and prospective studies, its...

  • Mortality in Co-Morbidity (II) - Excess Death Rates Derived from a Follow-up Study on 10,025 Subjects Divided Into 4 Groups with or Without Depression and Diabetes Mellitus. Milano, Anthony F.; Singer, Richard B. // Journal of Insurance Medicine;2007, Vol. 39 Issue 3, p160 

    Background.—Most mortality follow-up (FU) studies focus on excess mortality in a single risk factor or impairment. However, Many persons in the general population with 1 important medical risk factor are likely to have co-morbidity in the form of other risk factors, some minor, but others...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics